Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4258)
All Articles published online
|
Dec 14, 2011 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ruzzenente A, Valdegamberi A, Campagnaro T, Conci S, Pachera S, Iacono C, Guglielmi A. Hepatocellular carcinoma in cirrhotic patients with portal hypertension: Is liver resection always contraindicated? World J Gastroenterol 2011; 17(46): 5083-5088 [PMID: 22171142 DOI: 10.3748/wjg.v17.i46.5083] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v17/i46/5083.htm |
| Number | Citing Articles |
| 1 |
Nicolas Golse, Petru O. Bucur, René Adam, Denis Castaing, Antonio Sa Cunha, Eric Vibert. New Paradigms in Post-hepatectomy Liver Failure. Journal of Gastrointestinal Surgery 2013; 17(3): 593 doi: 10.1007/s11605-012-2048-6
|
| 2 |
Yun-Hao Tang, Wen-Jiang Zhu, Tian-Fu Wen. Influence of Clinically Significant Portal Hypertension on Hepatectomy for Hepatocellular Carcinoma: a Meta-analysis. Asian Pacific Journal of Cancer Prevention 2014; 15(4): 1649 doi: 10.7314/APJCP.2014.15.4.1649
|
| 3 |
Nam Hee Kim, Taeheon Lee, Yong Kyun Cho, Byung Ik Kim, Hong Joo Kim. Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization. Journal of Gastroenterology and Hepatology 2018; 33(7): 1397 doi: 10.1111/jgh.14083
|
| 4 |
Yichuan Yuan, Hong Peng, Wei He, Yun Zheng, Jiliang Qiu, Bin Chen, Ruhai Zou, Chenwei Wang, Wan Yee Lau, Binkui Li, Yunfei Yuan. Partial hepatectomy versus interventional treatment in patients with hepatitis B virus‐related hepatocellular carcinoma and clinically significant portal hypertension: a randomized comparative clinical trial. Cancer Communications 2024; 44(11): 1337 doi: 10.1002/cac2.12614
|
| 5 |
Jian-Hong Zhong, Hang Li, Nan Xiao, Xin-Ping Ye, Yang Ke, Yan-Yan Wang, Liang Ma, Jie Chen, Xue-Mei You, Zhi-Yuan Zhang, Shi-Dong Lu, Le-Qun Li, Devanand Sarkar. Hepatic Resection Is Safe and Effective for Patients with Hepatocellular Carcinoma and Portal Hypertension. PLoS ONE 2014; 9(9): e108755 doi: 10.1371/journal.pone.0108755
|
| 6 |
Astrit R Hamza, Avdyl S Krasniqi, Pramod Kadaba Srinivasan, Mamdouh Afify, Christian Bleilevens, Uwe Klinge, René H Tolba. Gut-liver axis improves with meloxicam treatment after cirrhotic liver resection. World Journal of Gastroenterology 2014; 20(40): 14841-14854 doi: 10.3748/wjg.v20.i40.14841
|
| 7 |
Jianwei Liu, Han Zhang, Yong Xia, Tian Yang, Yuzhen Gao, Jun Li, Yeye Wu, Feng Shen. Impact of clinically significant portal hypertension on outcomes after partial hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. HPB 2019; 21(1): 1 doi: 10.1016/j.hpb.2018.07.005
|
| 8 |
Maria C. Russell. Complications Following Hepatectomy. Surgical Oncology Clinics of North America 2015; 24(1): 73 doi: 10.1016/j.soc.2014.09.008
|
| 9 |
Simona Leoni, Fabio Piscaglia, Ilaria Serio, Eleonora Terzi, Irene Pettinari, Luca Croci, Sara Marinelli, Francesca Benevento, Rita Golfieri, Luigi Bolondi. Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: Experience of the Bologna Liver Oncology Group. Digestive and Liver Disease 2014; 46(6): 549 doi: 10.1016/j.dld.2014.02.012
|
| 10 |
Yang Huang, Jiulin Song, Jinli Zheng, Li Jiang, Lunan Yan, Jiayin Yang, Yong Zeng, Hong Wu. Comparison of Hepatic Resection Combined with Intraoperative Radiofrequency Ablation, or Hepatic Resection Alone, for Hepatocellular Carcinoma Patients with Multifocal Tumors Meeting the University of California San Francisco (UCSF) Criteria: A Propensity Score-Matched Analysis. Annals of Surgical Oncology 2020; 27(7): 2334 doi: 10.1245/s10434-020-08231-0
|
| 11 |
Sae Byeol Choi, Hyun Jung Kim, Tae Jin Song, Hyeong Sik Ahn, Sang Yong Choi. Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta‐analysis. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(9): 639 doi: 10.1002/jhbp.124
|
| 12 |
Zheng-Liang Chen, Lan-Qing Yao, Jia-Le Pu, Han Wu, Xin-Fei Xu, Ting-Hao Chen, Ya-Hao Zhou, Hong Wang, Zhi-Yu Chen, Li-Yang Sun, Yong-Kang Diao, Jian-Hong Zhong, Wan Yee Lau, Timothy M. Pawlik, Dong-Sheng Huang, Feng Shen, Ying-Jian Liang, Tian Yang. Impact of concurrent splenectomy and esophagogastric devascularization on surgical outcomes of partial hepatectomy for hepatocellular carcinoma in patients with clinically significant portal hypertension: A multicenter propensity score matching analysis. European Journal of Surgical Oncology 2022; 48(5): 1078 doi: 10.1016/j.ejso.2021.11.118
|
| 13 |
Badawy A. Abdulaziz, Waleed El Agawy, Mohamed El-Tantawy Ibrahim, Medhat A. Khalil, Walid A. Abdel Halim.
Significance of Carbohydrate Antigen 19-9 as a biomarker in Hepatocellular Carcinoma and Cholangiocarcinoma
. The Open Biomarkers Journal 2021; 11(1): 39 doi: 10.2174/1875318302111010039
|
| 14 |
Gonzalo Sapisochin, Elena Fernandez de Sevilla, Juan Echeverri, Ramón Charco. Management of “very early” hepatocellular carcinoma on cirrhotic patients. World Journal of Hepatology 2014; 6(11): 766-775 doi: 10.4254/wjh.v6.i11.766
|
| 15 |
Xian-Qiang Wang, Zhe Liu, Wen-Ping Lv, Ying Luo, Guang-Yun Yang, Chong-Hui Li, Xiang-Fei Meng, Yang Liu, Ke-Sen Xu, Jia-Hong Dong. Safety validation of decision trees for hepatocellular carcinoma. World Journal of Gastroenterology 2015; 21(31): 9394-9402 doi: 10.3748/wjg.v21.i31.9394
|
| 16 |
Qiang-Bo Zhang, Xiu-Guo Zhang, Run-de Jiang, Chun-Xiao Hu, Dong Sun, Lin Ran, Zong-Li Zhang. Microwave ablation versus hepatic resection for the treatment of hepatocellular carcinoma and oesophageal variceal bleeding in cirrhotic patients. International Journal of Hyperthermia 2017; 33(3): 255 doi: 10.1080/02656736.2016.1257824
|
| 17 |
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Consenso mexicano de diagnóstico y manejo del carcinoma hepatocelular. Revista de Gastroenterología de México 2014; 79(4): 250 doi: 10.1016/j.rgmx.2014.09.004
|
| 18 |
Mark Pines. Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. World Journal of Gastroenterology 2014; 20(40): 14778-14786 doi: 10.3748/wjg.v20.i40.14778
|
| 19 |
Wei He, Qingli Zeng, Yun Zheng, Meixian Chen, Jingxian Shen, Jiliang Qiu, Miao Chen, Ruhai Zou, Yadi Liao, Qijiong Li, Xianqiu Wu, Binkui Li, Yunfei Yuan. The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: a propensity score matching analysis. BMC Cancer 2015; 15(1) doi: 10.1186/s12885-015-1280-3
|
| 20 |
R. Santambrogio, J. Salceda, M. Costa, M.D. Kluger, M. Barabino, A. Laurent, E. Opocher, D. Azoulay, D. Cherqui. External validation of a simplified BCLC staging system for early hepatocellular carcinoma. European Journal of Surgical Oncology (EJSO) 2013; 39(8): 850 doi: 10.1016/j.ejso.2013.05.001
|
| 21 |
Xiao-Pei Li, Ying Liu, Chun-Qing Zhang. Correlation Between NAT2 Gene Polymorphism and Cirrhotic Portal Hypertension in the Chinese Population. Genetic Testing and Molecular Biomarkers 2015; 19(3): 138 doi: 10.1089/gtmb.2014.0283
|
| 22 |
Ferenc Jakab. Sebészi kockázat májbetegeken. Magyar Sebészet 2013; 66(3): 127 doi: 10.1556/maseb.66.2013.3.1
|
| 23 |
Hazem M. Zakaria, Emad H. Gad, Ali Nada, Anwar A. Abdelaleem, Doha Maher, Mohammad E. Abdel Samea, Alyaa Sabry. Hepatic resection for hepatocellular carcinoma in cirrhotic patients with portal hypertension. Surgical Practice 2016; 20(4): 149 doi: 10.1111/1744-1633.12215
|
| 24 |
Masaaki Hidaka, Susumu Eguchi, Takanobu Hara, Akihiko Soyama, Satomi Okada, Takashi Hamada, Shinichiro Ono, Tomohiko Adachi, Kengo Kanetaka, Mitsuhisa Takatsuki. A Predictive Formula for Portal Venous Pressure Prior to Liver Resection Using Directly Measured Values. Journal of Investigative Surgery 2020; 33(2): 118 doi: 10.1080/08941939.2018.1476631
|
| 25 |
Emil Iskandarov, Pramod Kadaba Srinivasan, Wang Xin, Christian Bleilevens, Mamdouh Afify, Astrit Hamza, Lai Wei, Koichiro Hata, Boyukkishi Agayev, Rene Tolba. Protective Effects of Adenosine Receptor Agonist in a Cirrhotic Liver Resection Model. Hepatitis Monthly 2016; 16(8) doi: 10.5812/hepatmon.36821
|
| 26 |
Kosuke Kobayashi, Emilie Uldry, Takashi Kokudo, Alessandra Cristaudi, Yoshikuni Kawaguchi, Chikara Shirata, Takamune Yamaguchi, Olivier Dormond, Rafael Duran, Kiyoshi Hasegawa, Nicolas Demartines, Nermin Halkic. Correlation Between Portal Pressure and Indocyanine Green Retention Rate is Unaffected by the Cause of Cirrhosis: A Prospective Study. World Journal of Surgery 2021; 45(8): 2546 doi: 10.1007/s00268-021-06111-6
|
| 27 |
Takashi Kokudo, Kiyoshi Hasegawa, Chikara Shirata, Meguri Tanimoto, Takeaki Ishizawa, Junichi Kaneko, Nobuhisa Akamatsu, Junichi Arita, Nicolas Demartines, Emilie Uldry, Norihiro Kokudo, Nermin Halkic. Assessment of Preoperative Liver Function for Surgical Decision Making in Patients with Hepatocellular Carcinoma. Liver Cancer 2019; 8(6): 447 doi: 10.1159/000501368
|
| 28 |
Shakira Hoque, Christy Kim, Mihir Desai, Pram Sirimana, Malin Katarina Schumacher, Sri Jasti, Mostafa Abasseri, Oliver M.Fisher, Francis Chu, Suhrid Lodh, Natalie Collier, Winston Liauw, Piotr Milkiewicz, Amany Zekry. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 321 doi: 10.1002/9781119756422.ch18
|
| 29 |
Annalisa Berzigotti, Maria Reig, Juan G. Abraldes, Jaime Bosch, Jordi Bruix. Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis. Hepatology 2015; 61(2): 526 doi: 10.1002/hep.27431
|
| 30 |
Tianfu Wen, Chuan Li, Lei Li. Operative Techniques in Liver Resection. 2016; : 13 doi: 10.1007/978-94-017-7411-6_3
|
| 31 |
Jian-Hong Zhong, Guido Torzilli, Hao Xing, Chao Li, Jun Han, Lei Liang, Han Zhang, Shu-Yang Dai, Le-Qun Li, Feng Shen, Tian Yang. Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clinical 2016; 6: 125 doi: 10.1016/j.bbacli.2016.10.001
|
| 32 |
Roberto Santambrogio, Michael D. Kluger, Mara Costa, Andrea Belli, Matteo Barabino, Alexis Laurent, Enrico Opocher, Daniel Azoulay, Daniel Cherqui. Hepatic resection for hepatocellular carcinoma in patients with Child–Pugh's A cirrhosis: is clinical evidence of portal hypertension a contraindication?. HPB 2013; 15(1): 78 doi: 10.1111/j.1477-2574.2012.00594.x
|
| 33 |
María Reig, Annalisa Berzigotti, Jordi Bruix. If portal hypertension predicts outcome in cirrhosis, why should this not be the case after surgical resection?. Liver International 2013; 33(10): 1454 doi: 10.1111/liv.12273
|
| 34 |
D. Bettinger, E. Knüppel, W. Euringer, H. C. Spangenberg, M. Rössle, R. Thimme, M. Schultheiß. Efficacy and safety of transjugular intrahepatic portosystemic shunt (TIPSS) in 40 patients with hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics 2015; 41(1): 126 doi: 10.1111/apt.12994
|
| 35 |
María Sarai González Huezo, Juan Francisco Sánchez Ávila. Mexican consensus on the diagnosis and management of hepatocellular carcinoma. Revista de Gastroenterología de México (English Edition) 2014; 79(4): 250 doi: 10.1016/j.rgmxen.2014.12.002
|